1. Home
  2. NUVL vs SSRM Comparison

NUVL vs SSRM Comparison

Compare NUVL & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$97.75

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Logo SSR Mining Inc.

SSRM

SSR Mining Inc.

HOLD

Current Price

$28.18

Market Cap

6.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
SSRM
Founded
2017
1946
Country
United States
United States
Employees
N/A
2900
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
6.5B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
SSRM
Price
$97.75
$28.18
Analyst Decision
Strong Buy
Buy
Analyst Count
15
4
Target Price
$135.33
$31.49
AVG Volume (30 Days)
436.1K
4.3M
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$58.93
Revenue Next Year
$1,064.25
$6.60
P/E Ratio
N/A
$14.37
Revenue Growth
N/A
N/A
52 Week Low
$55.54
$8.65
52 Week High
$113.02
$33.49

Technical Indicators

Market Signals
Indicator
NUVL
SSRM
Relative Strength Index (RSI) 42.01 47.25
Support Level $73.22 $27.80
Resistance Level $107.13 $28.81
Average True Range (ATR) 3.82 1.73
MACD -0.35 -0.45
Stochastic Oscillator 19.08 6.33

Price Performance

Historical Comparison
NUVL
SSRM

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About SSRM SSR Mining Inc.

SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.

Share on Social Networks: